JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1826
DELISTED
Apellis Pharmaceuticals
APLS
| $13.1M | ﹤0.01% |
427,046
+411,200
| +2,595% | +$11.4M |
|
|
ATVI
1827
PUT
DELISTED
Activision Blizzard
ATVI
| $13.1M | ﹤0.01% |
220,000
-50,000
| -19% | -$2.77M |
|
|
PPBI
1828
DELISTED
Pacific Premier Bancorp
PPBI
| $13.1M | ﹤0.01% |
400,675
-64,648
| -14% | -$2.11M |
|
1829
C.H. Robinson
CHRW
$17.5B
| $13M | ﹤0.01% |
166,860
+73,843
| +79% | +$5.88M |
|
1830
OR Royalties Inc
OR
$6.15B
| $13M | ﹤0.01% |
1,343,515
+1,167,585
| +664% | +$10.7M |
|
1831
CALL
Aflac
AFL
$60.7B
| $13M | ﹤0.01% |
246,400
+200,000
| +431% | +$10.6M |
|
|
HBI
1832
DELISTED
Hanesbrands
HBI
| $13M | ﹤0.01% |
877,410
-314,132
| -26% | -$4.78M |
|
|
ITCI
1833
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $13M | ﹤0.01% |
379,319
+164,495
| +77% | +$1.97M |
|
1834
Charles River Laboratories
CRL
$13.4B
| $13M | ﹤0.01% |
84,941
-48,181
| -36% | -$6.67M |
|
1835
OSI Systems
OSIS
$3.77B
| $12.9M | ﹤0.01% |
128,424
-52,397
| -29% | -$5.18M |
|
1836
Grand Canyon Education
LOPE
$3.79B
| $12.9M | ﹤0.01% |
135,002
+79,515
| +143% | +$7.34M |
|
1837
Herbalife
HLF
$1.28B
| $12.9M | ﹤0.01% |
270,999
-129,114
| -32% | -$5.59M |
|
|
INST
1838
DELISTED
Instructure, Inc.
INST
| $12.9M | ﹤0.01% |
267,598
+216,389
| +423% | +$10.1M |
|
1839
Williams-Sonoma
WSM
$28.5B
| $12.9M | ﹤0.01% |
350,972
-305,170
| -47% | -$10.6M |
|
1840
CALL
NXP Semiconductors
NXPI
$58.5B
| $12.9M | ﹤0.01% |
101,100
+19,400
| +24% | +$2.25M |
|
1841
PUT
BP
BP
$110B
| $12.8M | ﹤0.01% |
338,900
-124,700
| -27% | -$4.74M |
|
|
GHY
1842
PGIM Global High Yield Fund
GHY
$480M
| $12.8M | ﹤0.01% |
850,541
| – | – |
|
1843
CALL
EOG Resources
EOG
$74.2B
| $12.8M | ﹤0.01% |
152,500
| – | – |
|
1844
iShares MSCI South Korea ETF
EWY
$27.6B
| $12.7M | ﹤0.01% |
204,741
-2,771,400
| -93% | -$164M |
|
1845
iShares Morningstar US Equity ETF
ILCB
$1.33B
| $12.7M | ﹤0.01% |
276,008
+900
| +0.3% | +$39.5K |
|
1846
Ryman Hospitality Properties
RHP
$7.87B
| $12.7M | ﹤0.01% |
146,597
+27,523
| +23% | +$2.37M |
|
1847
Omnicell
OMCL
$1.72B
| $12.7M | ﹤0.01% |
155,394
+72,284
| +87% | +$5.55M |
|
1848
Liberty Media Series A
FWONA
$23.7B
| $12.7M | ﹤0.01% |
302,918
+57,978
| +24% | +$2.28M |
|
1849
Huntington Ingalls Industries
HII
$12.8B
| $12.7M | ﹤0.01% |
50,602
-60,900
| -55% | -$14.4M |
|
1850
Select Water Solutions
WTTR
$2.63B
| $12.7M | ﹤0.01% |
1,367,333
+400
| +0% | +$3.23K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.